Jon Burrows

Arts and Humanities · Social Sciences

9h-index1.4kcitations154works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical History and Innovations(40), Cancer Genomics and Diagnostics(14), Cancer, Hypoxia, and Metabolism(13), Monoclonal and Polyclonal Antibodies Research(13), Lung Cancer Treatments and Mutations(11)

Publications154 total

Reel Change
John Libbey Publishing eBooks·2022
Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results
Cancers·2021· 2 citedOpen Access
Introduction
Journal of British Cinema and Television·2017
Constraints
Palgrave Macmillan UK eBooks·2017
Turnover
Palgrave Macmillan UK eBooks·2017
Introduction
Palgrave Macmillan UK eBooks·2017
Capital
Palgrave Macmillan UK eBooks·2017
Suppliers
Palgrave Macmillan UK eBooks·2017
Conclusion
Palgrave Macmillan UK eBooks·2017
Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment
Annals of Oncology·2016· 55 citedOpen Access
Abstract 25: Whole genome sequencing and quantitative proteomics reveal HPV integration and HER2 overexpression in a patient with cervical cancer: Comprehensive omics analysis driving clinical treatment decisions
Clinical Cancer Research·2016
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non–Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib
Clinical Chemistry·2015· 11 citedOpen Access
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
Gastric Cancer·2015· 43 citedOpen Access
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy
Molecular Oncology·2015· 88 citedOpen Access
2397 Evaluation of MET using FISH, IHC, or mass spectrometry as a prognostic biomarker in patients with gastroesophageal cancer
European Journal of Cancer·2015
Abstract 3395: Clinical Survey of 19 actionable proteins in multiple indications using multiplex mass spectrometry
Cancer Research·2015
Abstract 566: ChemoPlex SRM assay predicts response to specific chemotherapeutic agents in NSCLC
Cancer Research·2015
Abstract 3397: A novel clinical tool that provides quantitative and accurate measurement of Met protein
Cancer Research·2015
Abstract 3398: Development of a mass spectrometry based antibody-drug conjugate biomarker panel
Cancer Research·2015
Abstract 4255: Development and clinical validation of a quantitative mass spectrometric assay for immuno-oncology targets in FFPE samples
Cancer Research·2015
page 1 of 8Next →

Frequent Co-authors

Todd Hembrough(27), Sheeno Thyparambil(22), David B. Krizman(15), Marlene Darfler(13), Wei‐Li Liao(10), Franco Cecchi(9), Les Henderson(8), Kathleen Bengali(7), Daniel V.T. Catenacci(7), Peng Xu(7), William Hoos(5), Maurizio Scaltriti(5), Adele Blackler(5), Lei Zhao(5), Shu‐Yuan Xiao(5), Jamar Uzzell(5), Paolo Nucíforo(4), Ana C. Garrido-Castro(4), Vicente Peg(4), José Jiménez(4)